SG11202108837WA - Fcmr-binding molecules and uses thereof - Google Patents

Fcmr-binding molecules and uses thereof

Info

Publication number
SG11202108837WA
SG11202108837WA SG11202108837WA SG11202108837WA SG11202108837WA SG 11202108837W A SG11202108837W A SG 11202108837WA SG 11202108837W A SG11202108837W A SG 11202108837WA SG 11202108837W A SG11202108837W A SG 11202108837WA SG 11202108837W A SG11202108837W A SG 11202108837WA
Authority
SG
Singapore
Prior art keywords
fcmr
binding molecules
molecules
binding
Prior art date
Application number
SG11202108837WA
Inventor
Richard Brokx
Jacqueline M Mason
Mark R Bray
Original Assignee
Univ Health Network
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Health Network filed Critical Univ Health Network
Publication of SG11202108837WA publication Critical patent/SG11202108837WA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75—Agonist effect on antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202108837WA 2019-02-15 2020-02-14 Fcmr-binding molecules and uses thereof SG11202108837WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962806237P 2019-02-15 2019-02-15
PCT/CA2020/050195 WO2020163962A1 (en) 2019-02-15 2020-02-14 Fcmr-binding molecules and uses thereof

Publications (1)

Publication Number Publication Date
SG11202108837WA true SG11202108837WA (en) 2021-09-29

Family

ID=72043773

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202108837WA SG11202108837WA (en) 2019-02-15 2020-02-14 Fcmr-binding molecules and uses thereof

Country Status (14)

Country Link
US (1) US20220089725A1 (en)
EP (1) EP3924388A4 (en)
JP (1) JP2022520817A (en)
KR (1) KR20210139273A (en)
CN (1) CN113993895A (en)
AU (1) AU2020222408A1 (en)
BR (1) BR112021016102A2 (en)
CA (1) CA3130225A1 (en)
EA (1) EA202192254A1 (en)
IL (1) IL285585A (en)
MX (1) MX2021009767A (en)
SG (1) SG11202108837WA (en)
TW (1) TW202035461A (en)
WO (1) WO2020163962A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6200437B2 (en) * 2012-03-16 2017-09-20 ユニバーシティ ヘルス ネットワーク Methods and compositions for modulating TOSO activity
AU2014286869A1 (en) * 2013-07-03 2016-02-11 University Health Network Antibodies to Toso
ES2690420T3 (en) * 2015-05-28 2018-11-20 Universität Zu Köln Anti-cough chimeric antigen receptor and its use

Also Published As

Publication number Publication date
CA3130225A1 (en) 2020-08-20
TW202035461A (en) 2020-10-01
MX2021009767A (en) 2021-11-17
EA202192254A1 (en) 2021-11-29
IL285585A (en) 2021-09-30
EP3924388A1 (en) 2021-12-22
EP3924388A4 (en) 2023-02-15
KR20210139273A (en) 2021-11-22
WO2020163962A1 (en) 2020-08-20
AU2020222408A1 (en) 2021-09-09
CN113993895A (en) 2022-01-28
US20220089725A1 (en) 2022-03-24
BR112021016102A2 (en) 2021-11-09
JP2022520817A (en) 2022-04-01

Similar Documents

Publication Publication Date Title
EP3672991A4 (en) Anti-cd137 molecules and use thereof
IL269534A (en) Chimeric molecules and uses thereof
IL281568A (en) Collagen-localized immunomodulatory molecules and methods thereof
EP3331549A4 (en) Improved microbe-binding molecules and uses thereof
EP4076448A4 (en) Fluoroalkyl-oxadiazoles and uses thereof
IL293377B1 (en) Hsd17b13 variants and uses thereof
EP3511407A4 (en) Christensenella intestinihominis and application thereof
IL287765A (en) Tigit and pd-1/tigit-binding molecules
ZA201806597B (en) Ilt7 binding molecules and methods of using the same
IL278832A (en) Optimized gp41-binding molecules and uses thereof
IL289415A (en) Claudin-6 binding molecules and uses thereof
IL288314A (en) Anti-tdp-43 binding molecules and uses thereof
ZA202105847B (en) Mtroc modulators and uses thereof
EP3537895A4 (en) Novel mogrosides and use thereof
EP3589290A4 (en) Translatable molecules and synthesis thereof
SG11202006459XA (en) Proteinaceous molecules and uses therefor
IL278019A (en) Trans-splicing molecules
EP3630732A4 (en) Method and molecules
EP4006048A4 (en) Novel micropeptide hmmw and application thereof
IL284781A (en) Lilrb3-binding molecules and uses therefor
IL280369A (en) New myokines and uses thereof
IL285585A (en) Fcmr-binding molecules and uses thereof
EP4081255A4 (en) Anti-csf1r molecules and use thereof
TWI844756B (en) Anti-csf1r molecules and use thereof
IL287503A (en) Thiosemicarbazates and uses thereof